menu
    • menu

    Company profile for IsoPlexis

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The future of immune medicine holds promise for lasting and durable impact on many diseases; our high resolution systems are powering the development and further personalization of these curative medicines. IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise, award-winning detection systems. By revealing unique immune biomarkers in small s...
    The future of immune medicine holds promise for lasting and durable impact on many diseases; our high resolution systems are powering the development and further personalization of these curative medicines. IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise, award-winning detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IsoPlexisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    35 NE Industrial Rd, Branford, CT 06405
    Telephone
    Telephone
    (475) 221-8402
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://isoplexis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IsoPlexis Reports Preliminary Full Year 2022 Revenue
    IsoPlexis Reports Preliminary Full Year 2022 Revenue

    12 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/12/2588284/0/en/IsoPlexis-Reports-Preliminary-Full-Year-2022-Revenue.html

    GLOBENEWSWIRE
    12 Jan 2023
    Share Share
    Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology
    Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology

    21 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/21/2578263/0/en/Berkeley-Lights-to-Acquire-IsoPlexis-Creating-a-Premier-Functional-Cell-Biology-Company.html

    GLOBENEWSWIRE
    21 Dec 2022
    Share Share
    IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022
    IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

    19 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/19/2537221/0/en/IsoPlexis-to-Report-Third-Quarter-2022-Financial-Results-on-November-10-2022.html

    GLOBENEWSWIRE
    19 Oct 2022
    Share Share
    IsoPlexis Announces First APAC Publication, Illustrating Early Impact Codeplex
    IsoPlexis Announces First APAC Publication, Illustrating Early Impact Codeplex

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2514842/0/en/IsoPlexis-Announces-First-APAC-Publication-Illustrating-Early-Impact-of-Codeplex-Platform.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    IsoPlexis Partners with MediMergent & The Center for Blood Disorders of AZD7442
    IsoPlexis Partners with MediMergent & The Center for Blood Disorders of AZD7442

    06 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/06/2510198/0/en/IsoPlexis-Partners-with-MediMergent-and-The-Center-for-Cancer-and-Blood-Disorders-in-Study-of-AZD7442-for-Prevention-of-COVID-19-Infection-in-Immuno-Compromised-Cancer-Patients.html

    GLOBENEWSWIRE
    06 Sep 2022
    Share Share
    IsoPlexis Appointments Nachum “Homi” Shamir to its Board of Directors
    IsoPlexis Appointments Nachum “Homi” Shamir to its Board of Directors

    23 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/23/2502818/0/en/IsoPlexis-Announces-the-Appointment-of-former-Luminex-Corporation-Chairman-and-CEO-Nachum-Homi-Shamir-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    23 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search